425 related articles for article (PubMed ID: 38067618)
1. Introduction of Carbonyl Groups into Antibodies.
Gulyak EL; Alferova VA; Korshun VA; Sapozhnikova KA
Molecules; 2023 Dec; 28(23):. PubMed ID: 38067618
[TBL] [Abstract][Full Text] [Related]
2. Antibody-drug conjugates and bispecific antibodies targeting cancers: applications of click chemistry.
Hong Y; Nam SM; Moon A
Arch Pharm Res; 2023 Mar; 46(3):131-148. PubMed ID: 36877356
[TBL] [Abstract][Full Text] [Related]
3. Recent Chemical Approaches for Site-Specific Conjugation of Native Antibodies: Technologies toward Next-Generation Antibody-Drug Conjugates.
Yamada K; Ito Y
Chembiochem; 2019 Nov; 20(21):2729-2737. PubMed ID: 30973187
[TBL] [Abstract][Full Text] [Related]
4. The next generation of antibody drug conjugates.
Mack F; Ritchie M; Sapra P
Semin Oncol; 2014 Oct; 41(5):637-52. PubMed ID: 25440608
[TBL] [Abstract][Full Text] [Related]
5. Antibody drug conjugates: lessons from 20 years of clinical experience.
Tolcher AW
Ann Oncol; 2016 Dec; 27(12):2168-2172. PubMed ID: 27733376
[TBL] [Abstract][Full Text] [Related]
6. Antibody drug conjugates: Progress, pitfalls, and promises.
Mukherjee A; Waters AK; Babic I; Nurmemmedov E; Glassy MC; Kesari S; Yenugonda VM
Hum Antibodies; 2019; 27(1):53-62. PubMed ID: 30223393
[TBL] [Abstract][Full Text] [Related]
7. Efficient Preparation of Site-Specific Antibody-Drug Conjugates Using Cysteine Insertion.
Dimasi N; Fleming R; Zhong H; Bezabeh B; Kinneer K; Christie RJ; Fazenbaker C; Wu H; Gao C
Mol Pharm; 2017 May; 14(5):1501-1516. PubMed ID: 28245132
[TBL] [Abstract][Full Text] [Related]
8. Antibody-Drug Conjugates for Cancer Therapy.
Hafeez U; Parakh S; Gan HK; Scott AM
Molecules; 2020 Oct; 25(20):. PubMed ID: 33081383
[TBL] [Abstract][Full Text] [Related]
9. Picking the optimal target for antibody-drug conjugates.
Mathur R; Weiner GJ
Am Soc Clin Oncol Educ Book; 2013; ():. PubMed ID: 23714470
[TBL] [Abstract][Full Text] [Related]
10. The target invites a foe: antibody-drug conjugates in gynecologic oncology.
Campos MP; Konecny GE
Curr Opin Obstet Gynecol; 2018 Feb; 30(1):44-50. PubMed ID: 29227302
[TBL] [Abstract][Full Text] [Related]
11. Antibody-drug conjugates in clinical trials for lymphoid malignancies and multiple myeloma.
Yu B; Liu D
J Hematol Oncol; 2019 Sep; 12(1):94. PubMed ID: 31500657
[TBL] [Abstract][Full Text] [Related]
12. Site-specific antibody drug conjugates for cancer therapy.
Panowski S; Bhakta S; Raab H; Polakis P; Junutula JR
MAbs; 2014; 6(1):34-45. PubMed ID: 24423619
[TBL] [Abstract][Full Text] [Related]
13. Implementing antibody-drug conjugates (ADCs) in HER2-positive breast cancer: state of the art and future directions.
Ferraro E; Drago JZ; Modi S
Breast Cancer Res; 2021 Aug; 23(1):84. PubMed ID: 34380530
[TBL] [Abstract][Full Text] [Related]
14. Aminooxy Click Modification of a Periodate-Oxidized Immunoglobulin G: A General Approach to Antibody-Drug Conjugates with Dye-Mediated Expeditious Stoichiometry Control.
Sapozhnikova KA; Gulyak EL; Brylev VA; Misyurin VA; Oreshkov SD; Alexeeva AV; Ryazantsev DY; Simonova MA; Ryabukhina EV; Popova GP; Tikhonova NA; Lyzhko NA; Barmashov AE; Misyurin AV; Ustinov AV; Alferova VA; Korshun VA
Int J Mol Sci; 2023 Mar; 24(6):. PubMed ID: 36982208
[TBL] [Abstract][Full Text] [Related]
15. ADCs, as Novel Revolutionary Weapons for Providing a Step Forward in Targeted Therapy of Malignancies.
Amani N; Dorkoosh FA; Mobedi H
Curr Drug Deliv; 2020; 17(1):23-51. PubMed ID: 31755387
[TBL] [Abstract][Full Text] [Related]
16. Antibody-targeted drugs and drug resistance--challenges and solutions.
Shefet-Carasso L; Benhar I
Drug Resist Updat; 2015 Jan; 18():36-46. PubMed ID: 25476546
[TBL] [Abstract][Full Text] [Related]
17. The clinical development of antibody-drug conjugates - lessons from leukaemia.
Jabbour E; Paul S; Kantarjian H
Nat Rev Clin Oncol; 2021 Jul; 18(7):418-433. PubMed ID: 33758376
[TBL] [Abstract][Full Text] [Related]
18. Antibody-drug conjugates: an emerging modality for the treatment of cancer.
Leal M; Sapra P; Hurvitz SA; Senter P; Wahl A; Schutten M; Shah DK; Haddish-Berhane N; Kabbarah O
Ann N Y Acad Sci; 2014 Aug; 1321():41-54. PubMed ID: 25123209
[TBL] [Abstract][Full Text] [Related]
19. Antibody Glycoengineering and Homogeneous Antibody-Drug Conjugate Preparation.
Manabe S; Yamaguchi Y
Chem Rec; 2021 Nov; 21(11):3005-3014. PubMed ID: 33886147
[TBL] [Abstract][Full Text] [Related]
20. Antibody-Drug Conjugates for Tumor Targeting-Novel Conjugation Chemistries and the Promise of non-IgG Binding Proteins.
Merten H; Brandl F; Plückthun A; Zangemeister-Wittke U
Bioconjug Chem; 2015 Nov; 26(11):2176-85. PubMed ID: 26086208
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]